News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
663,131 Results
Type
Article (33606)
Company Profile (642)
Press Release (628883)
Section
Business (203060)
Career Advice (2183)
Deals (37163)
Drug Delivery (103)
Drug Development (80536)
Employer Resources (165)
FDA (15704)
Job Trends (14991)
News (343492)
Policy (30216)
Tag
Academia (1325)
Alliances (48806)
Alzheimer's disease (1238)
Approvals (15654)
Artificial intelligence (185)
Bankruptcy (371)
Best Places to Work (11042)
Biotechnology (438)
Breast cancer (189)
Cancer (1486)
Cardiovascular disease (120)
Career advice (1798)
Cell therapy (329)
Clinical research (65168)
Collaboration (619)
Compensation (314)
COVID-19 (2200)
C-suite (153)
Data (1462)
Diabetes (186)
Diagnostics (6223)
Earnings (84085)
Employer resources (142)
Events (110804)
Executive appointments (533)
FDA (16477)
Funding (538)
Gene therapy (225)
GLP-1 (667)
Government (3005)
Healthcare (16018)
Infectious disease (2294)
Inflammatory bowel disease (118)
Interviews (430)
IPO (17262)
Job creations (4410)
Job search strategy (1504)
Layoffs (498)
Legal (7658)
Lung cancer (221)
Manufacturing (240)
Medical device (13456)
Medtech (13461)
Mergers & acquisitions (20197)
Metabolic disorders (519)
Neuroscience (1638)
NextGen: Class of 2025 (6030)
Non-profit (2031)
Northern California (1926)
Obesity (297)
Opinion (236)
Patents (142)
People (57395)
Pharmaceutical (133)
Phase I (20369)
Phase II (29005)
Phase III (21575)
Pipeline (640)
Postmarket research (2137)
Preclinical (8288)
Radiopharmaceuticals (255)
Rare diseases (303)
Real estate (6014)
Regulatory (21076)
Research institute (1388)
Resumes & cover letters (342)
Southern California (1659)
Startups (3927)
United States (17332)
Vaccines (564)
Weight loss (217)
Date
Today (152)
Last 7 days (627)
Last 30 days (2628)
Last 365 days (35521)
2025 (2635)
2024 (35957)
2023 (40682)
2022 (51209)
2021 (54624)
2020 (51621)
2019 (42553)
2018 (32492)
2017 (33104)
2016 (31455)
2015 (36935)
2014 (30162)
2013 (25293)
2012 (26877)
2011 (27035)
2010 (25026)
Location
Africa (692)
Arizona (149)
Asia (42502)
Australia (6794)
California (4500)
Canada (1593)
China (379)
Colorado (197)
Connecticut (217)
Europe (89114)
Florida (596)
Georgia (151)
Illinois (374)
Indiana (259)
Maryland (619)
Massachusetts (3583)
Michigan (200)
Minnesota (327)
New Jersey (1253)
New York (1252)
North Carolina (895)
Northern California (1926)
Ohio (147)
Pennsylvania (1004)
South America (1094)
Southern California (1659)
Texas (644)
Utah (128)
Washington State (454)
663,131 Results for "ono pharmaceutical company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)
Ono Pharmaceutical, Co., Ltd. (Chairman and CEO: Gyo Sagara, “Ono”) today announced that it has successfully completed the tender offer, previously announced on April 30, 2024 to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc.
June 11, 2024
·
5 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Deals
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
ONO Pharmaceutical, Co., Ltd., and Deciphera Pharmaceuticals, Inc. announced that on April 29, 2024, ONO and Deciphera entered into a definitive merger agreement under which ONO will acquire all outstanding shares of Deciphera common stock for US $ 25.60 per share in cash through a tender offer followed by a merger of a wholly owned subsidiary of ONO with and into Deciphera with Deciphera surviving as a wholly owned subsidiary of ONO.
April 30, 2024
·
10 min read
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono
PRISM BioLab, Co. Ltd. announced that it has entered into a target-exclusive research and licensing agreement with ONO PHARMACEUTICAL CO., LTD.
April 25, 2024
·
3 min read
Press Releases
Kinaxis to Bolster Supply Chain Operations of Ono Pharmaceutical
October 7, 2024
·
2 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System Disorders
Sibylla Biotech announced a drug discovery collaboration with Ono Pharmaceutical Co., Ltd. that will access Sibylla’s cutting-edge Pharmacological Protein Inactivation by Folding Intermediates Targeting technology to identify and develop candidates for multiple therapeutic targets in the field of Central Nervous System disorders.
March 14, 2024
·
3 min read
Press Releases
Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical
September 12, 2024
·
4 min read
Business
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK) today announces a worldwide drug discovery collaboration with Ono Pharmaceutical Co., Ltd. (Ono), to generate novel bifunctional fusion proteins targeting certain pathways in autoimmune and inflammatory diseases.
February 13, 2024
·
5 min read
Business
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
BioMed X announced a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan.
December 19, 2023
·
3 min read
1 of 66,314
Next
